✦ LIBER ✦

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes

✍ Scribed by T. Heise; L. Nosek; S. G. Bøttcher; H. Hastrup; H. Haahr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin and glucose profiles during cont

✍ T. Parkner; T. Laursen; E. T. Vestergaard; H. Hartvig; J. S. Smedegaard; T. Laur 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Insulin degludec, an ultra-long-acting b

✍ Bernard Zinman; Greg Fulcher; Paturi V Rao; Nihal Thomas; Lars A Endahl; Thue Jo 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 203 KB

The glucose lowering effect of an oral i

✍ S. D. Luzio; G. Dunseath; A. Lockett; T. P. Broke-Smith; R. R. New; D. R. Owens 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

54 EFFECT OF ONE YEAR TREATMENT WITH INS

✍ Søgaard Lund, S.; Tarnow, L.; Nielsen, B.; Hansen, B.; Frandsen, M.; Pedersen, O 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Effects of Once-Weekly Dosing of a Long-

✍ Kim, D.; MacConell, L.; Zhuang, D.; Kothare, P. A.; Trautmann, M.; Fineman, M.; 📂 Article 📅 2007 🏛 American Diabetes Association 🌐 English ⚖ 388 KB

PDB55 Estimating the Cost-Effectiveness

✍ B. Curtis; R. Pollock; J. Smith-Palmer; W. Valentine 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB